Cognoptix
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
33 Boston Post Rd W Ste 140, Marlborough...Phone Number
(508) 251-1546Website
www.cognoptix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Cognoptix
Cognoptix is a pioneering company focused on developing a non-invasive beta amyloid eye scanning test for the early detection and diagnosis of Alzheimer's Disease. Their innovative Sapphire II system allows for a simple eye scan that can be performed in a doctor's office, addressing the significant unmet need for accurate and cost-effective diagnostic methods. Co-founded by Dr. Lee Goldstein and Dr. Leo Chylack, the company aims to empower physicians and patients in managing cognitive health through early intervention. Cognoptix is actively forming strategic alliances with pharmaceutical partners and academic institutions to advance its diagnostic platform for clinical use.Explore more
Cognoptix Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cognoptix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Cognoptix
Product Launch: Get notified when Cognoptix launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Cognoptix has new funding data
Check if Cognoptix has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Cognoptix had a recent Job posting/layoffs
Earning: See what the market has to say on Cognoptix recently announced quarterly report
Cognoptix, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Cognoptix is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Cognoptix
Compare insights from companies similar to Cognoptix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cognoptix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cognoptix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cognoptix.
Cognoptix financials insights
Gather financial insights about Cognoptix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$1M
2008
Series B
$18.5M
2011
Series C
$4.6M
2014
Debt
$390K
Series D
$15M
2020
Other Financing Round
$2.6M
Cognoptix Tech Stack
A closer look at the technologies used by Cognoptix
Most Recent Scoops
Executive Move
New Hire
Executive Move
New Hire
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Cognoptix News & Media
Cognoptix President & CEO, Susanne Wilke, PhD, MBA, to Present at Sachs 4th Annual Neuroscience Innovation Forum
MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ -- Cognoptix, a leading medical device/diagnostics company dedicated to the early detection of Alzheimer's disease (AD), announced today that Dr. Susanne Wilke, the Company's President and Chief Executive Officer, will present a "Spotlight...Cognoptix CEO Dr. Susanne Wilke to Present at the 13th Annual BIOTECH SHOWCASE™ DIGITAL Event
MARLBOROUGH, Mass., Jan. 11, 2021 /PRNewswire/ -- Cognoptix, a privately-held, diagnostics company with a breakthrough technology for the early detection of Alzheimer's disease (AD), announces that the company will present at the 13th Annual Biotech Showcase™ Digital Event, January 11-15,...Cognoptix Appoints New Chief Medical Officer, Dr. Carl Sadowsky, MD, And Chief Financial Officer, Mike Kaswan, MBA, To Management Team
MARLBOROUGH, Mass., Jan. 4, 2021 /PRNewswire/ -- Cognoptix, a leading diagnostics company dedicated to the early detection of Alzheimer's disease (AD), announces two appointments to its senior management team. Dr. Carl H. Sadowsky, MD will serve as the company's new Chief Medical Officer...Cognoptix Appoints New Chief Medical Officer, Dr. Carl Sadowsky, MD, And Chief Financial Officer ...
Cognoptix, a leading diagnostics company dedicated to the early detection of Alzheimer's disease (AD), announces two appointments to its senior management team. Dr. Carl H. Sadowsky, MD will serve as the company's new Chief Medical Officer (CMO) and Mike Kaswan, MBA will be Cognoptix's Chief Financial Officer (CFO).
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cognoptix
Sign Up For FreeTo access detailed company insights
Cognoptix is a pioneering company focused on developing a non-invasive beta amyloid eye scanning test for the early detection and diagnosis of Alzheimer's Disease. Their innovative Sapphire II system allows for a simple eye scan that can be performed in a doctor's office, addressing the significant unmet need for accurate and cost-effective diagnos... Read More
